|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07F 9/6506 | |
| A61K 31/675 | |||
| A61P 35/00 | |||
| C07F 9/6539 | |||
| A61K 31/337 | |||
| A61K 31/513 | |||
| A61K 31/7068 | |||
| A61K 33/24 |
| (11) | Number of the document | 2336141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11157963.7 |
| Date of filing the European patent application | 2006-06-29 | |
| (97) | Date of publication of the European application | 2011-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 695755 P | 2005-06-29 | US |
| (72) |
Matteucci, Mark, US
Duan, Jian-Xin, US
Jiao, Hailong, US
Kaizerman, Jacob, US
|
| (73) |
Threshold Pharmaceuticals, Inc.,
170 Harbor Way, Suite 300, South San Francisco, CA 94080,
US
|
| (54) | PHOSPHORAMIDATE ALKYLATOR PRODRUGS |
| PHOSPHORAMIDATE ALKYLATOR PRODRUGS |